Patents by Inventor Pascal HOUZE

Pascal HOUZE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Microfluidic asymmetric flow field-flow fractionation device and method of using the same
    Patent number: 11946909
    Abstract: The present invention relates to an asymmetric flow field-flow fractionation device (1) configured to separate a sample (8) of particles (12) dispersed in a liquid mobile phase (11), the device including a fractionation microchannel (2) comprising a sample inlet, a sample outlet, an auxiliary microchannel (3) comprising an auxiliary outlet, a semipermeable membrane (10) separating the fractionation microchannel (2) and the auxiliary microchannel (3), said membrane being permeable to liquid and being configured to maintain the particles (12) in said fractionation microchannel (2), the fractionation microchannel (2) being superimposed on the auxiliary microchannel (3), wherein the device (1) comprises two layers (19), each layer being with a microfabricated recess (14) which thickness (t) is less than 100IJm, the membrane (10) being mechanically held in between the two layers (19), the recesses (14) respectively defining the fractionation microchannel (2) and the auxiliary microchannel (3) on each side of the m
    Type: Grant
    Filed: February 21, 2019
    Date of Patent: April 2, 2024
    Assignees: Assistance Publique-Hopitaux de Paris, Centre National de la Recherche Scientifique (CNRS), Institut National de le Recherche Scientifique (CNRS), UNIVERSITÉ PARIS CITÉ, Ecole Nationale Superieure de Chimie de Paris
    Inventors: Hugo Salmon, Rabah Gahoual, Nathalie Mignet, Pascal Houze
  • Microfluidic Asymmetric Flow Field-Flow Fractionation Device And Method Of Using The Same
    Publication number: 20210088483
    Abstract: The present invention relates to an asymmetric flow field-flow fractionation device (1) configured to separate a sample (8) of particles (12) dispersed in a liquid mobile phase (11), the device including a fractionation microchannel (2) comprising a sample inlet, a sample outlet, an auxiliary microchannel (3) comprising an auxiliary outlet, a semipermeable membrane (10) separating the fractionation microchannel (2) and the auxiliary microchannel (3), said membrane being permeable to liquid and being configured to maintain the particles (12) in said fractionation microchannel (2), the fractionation microchannel (2) being superimposed on the auxiliary microchannel (3), wherein the device (1) comprises two layers (19), each layer being with a microfabricated recess (14) which thickness (t) is less than 100IJm, the membrane (10) being mechanically held in between the two layers (19), the recesses (14) respectively defining the fractionation microchannel (2) and the auxiliary microchannel (3) on each side of the m
    Type: Application
    Filed: February 21, 2019
    Publication date: March 25, 2021
    Applicants: Assistance Publique-Hopitaux de Paris, Centre National de la Recherche Scientifique (CNRS), Institut National de la Sante et de la Recherche Medicale (INSERM), Universite De Paris, Ecole Nationale Superieure de Chimie de Paris
    Inventors: Hugo Salmon, Rabah Gahoual, Nathalie Mignet, Pascal Houze
  • Composition that comprises at least one oxime and its use in therapeutics
    Patent number: 8604066
    Abstract: A medication, a pharmaceutical composition, and method for the treatment of respiratory poisoning in animals and humans caused by organophosphorus compounds, whereby said medication and said pharmaceutical composition comprise at least one oxime and one blocker of organic cation transporters (OCT).
    Type: Grant
    Filed: September 28, 2011
    Date of Patent: December 10, 2013
    Assignee: SERB
    Inventors: Frédéric J. Baud, Pascal Houze, Maya Kayouka
  • COMPOSITION THAT COMPRISES AT LEAST ONE OXIME AND ITS USE IN THERAPEUTICS
    Publication number: 20120041037
    Abstract: A medication, a pharmaceutical composition, and method for the treatment of respiratory poisoning in animals and humans caused by organophosphorus compounds, whereby said medication and said pharmaceutical composition comprise at least one oxime and one blocker of organic cation transporters (OCT).
    Type: Application
    Filed: September 28, 2011
    Publication date: February 16, 2012
    Applicant: SERB
    Inventors: Frédéric J. BAUD, Pascal HOUZE, Maya KAYOUKA
  • COMPOSITION THAT COMPRISES AT LEAST ONE OXIME AND ITS USE IN THERAPEUTICS
    Publication number: 20090156650
    Abstract: This invention relates to a medication, a pharmaceutical composition. and method for the treatment of respiratory poisoning in animals and humans caused by organophosphorus compounds, whereby said medication and said pharmaceutical composition comprise at least one oxime and one blocker of organic cation transporters (OCT).
    Type: Application
    Filed: September 19, 2008
    Publication date: June 18, 2009
    Applicant: SERB
    Inventors: Frederic BAUD, Pascal HOUZE, Maya KAYOUKA